Essilor International Compagnie Generale d'Optique SA EI Financial and Strategic SWOT Analysis Review [Report Updated: 05072018] Prices from USD $125

08:36 EDT 12 Aug 2018 | BioPortfolio Report Blog

Essilor International Compagnie Generale d'Optique SA EI Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Essilor International Essilor designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatism. It also manufactures and sells nonprescription reading glasses, sunglasses, equipment, instruments and consumables used by prescription laboratories and eyecare professionals. Essilor has manufacturing facilities across North America, Latin America, Europe and Asia Middle East, Russia and Africa AMERA. The company sells its products through a network of distributors in the Americas, Europe, the Middle East, Africa and AsiaPacific. Essilor is headquartered in Paris, France.

Essilor International Compagnie Generale d'Optique SA Key Recent Developments

Jun 21,2018: Essilor moves up in Forbes World's 100 Most Innovative Companies annual ranking

May 29,2018: Essilor partners with the Government of Odisha to launch livelihood building programme, Eye Mitra

Apr 24,2018: Essilor announces changes in Board of Directors

Apr 16,2018: Essilor to put proven expertise of vision care capacitybuilding at the service of the Commonwealth

Mar 01,2018: Essilor to allocate exceptional French tax refund to the Group's initiatives to eradicate poor vision

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Essilor International Compagnie Generale d'Optique SA EI Financial and Strategic SWOT Analysis Review [Report Updated: 05072018] Prices from USD $125


More From BioPortfolio on "Essilor International Compagnie Generale d'Optique SA EI Financial and Strategic SWOT Analysis Review [Report Updated: 05072018] Prices from USD $125"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...